AR226-2253 / Debbie J Mulrooney 01/30/2002 06:13 PM To: cc: Subject: Robert F Pinchot/DEV/AE/DuPont@DuPont Re: Watershed Deposition Results D Rob, The areas are: Little Hocking - 2.57 km2 Lake Washington - 2.8 km2 Robert F Pinchot 01/30/2002 10:38 AM __ Robert F Pinchot 01/30/2002 10:38 AM To: cc: Subject: Debbie J Muli-ooney/AE/DuPont@DuPont Re: Watershed Deposition Results Q Debbie, Thanks a bunch.

Substances PTFE CAS No.

To: Cc: From: Sent: Subject: Received: restrictiePFAS] @mmm.com] @rivm ni]; IEE EEF @raE mboll.com) Mon 1/25/2021 11:01:14 AM RE: PFAS Waste study / Ramboll contact Mon 1/25/2021 11:01:15 AM [EXER Dear No problem.

AR226-2289 Robbin Banerjee muai/uM4i/um^ Un72..'

Comment on Proposed Restriction of PFAS May 30, 2023 Japan Fluoropolymers Industry Association (JFIA) We, Japan Fluoropolymers Industry Association (JFIA), think that fluoropolymers should be distinguished from the proposed restriction of PFAS (Per- and polyfluoroalkyl substances), which collectively regulates more than 10,000 of organofluorine compounds (PFAS) on the grouping basis.

AR226-2294 DRAFT 3 DuPont Statement on January 7, 2003, Letter from Ohio EPA Regarding "Air impacts in Ohio due to emissions of C8" In a January 7, 2003, letter to Paul Bossert, Plant Manager at DuPont Washington Works, Ohio EPA Director Christopher Jones refers to "concern over ambient levels of C8, as predicted by air quality modeling of year 2000 actual emissions."

AR226-2315 /y Charles J Zarzecki 03/19/2003 11:31 AM To: cc: Subject Catherine A Barton/AE/DuPont WVC8 Modeling Cathie, I took a look at the location of the maximum predictions in the VW C8 modeling summary.

English edition (This document is only for reference.

AR226-2409 INTEROFFICE MEMORANDUM Dates From; Dept: Tel No: 29-May-1990 12:23pm Peter D.

Position statement by MedicalMountains GmbH on the proposal for a restriction on per- and polyfluoroalkyl substances (PFASs) Version 2.0 www.medicalmountains.de POSITION STATEMENT (MedicalMountains MED ALLIANCE BW File Version 2.0 August 2023 Contact: MedicalMountains GmbH Katharinenstrasse 2 D-78532 Tuttlingen Germany Julia Steckeler CEO @medicalmountains.de Phone +49 7461 969721-2 Meinrad Kempf Project manager M@medicalmountains.de Phone +49 7461 969721-8 www.medicalmountains.de 1 Contents 1.

Aug 1, 2023 Comment on Proposed Restriction of PFAS Japan Valve Manufacturers' Association (JVMA) Japan Valve Manufacturers' Association (JVMA) appreciates the opportunity to provide comments to the PFAS restriction proposal. 1.

Transcript presenta,on PU in the sustainability and circular world By Bart J. ten Brink For Interna:onal PU Forum Nagoya Japan June 2023 Ladies and gentlemen, it's my real honor and pleasure to present in the Interna6onal PU Forum 2023, the presenta6on of what polyurethane is doing to the sustainability and circular world and what are the impacts for the PU-industry, next to what has been done worldwide in efforts to deal with all these trends.

AR226-2481 Roger J Zpfel 11/08/2000 02:35 PM To: cc; Subject: shamrockl wirefire.com Results from extraction studies Jeff.

From: boCc: Subject: Date: Attachments: 5.1.2e : ry RE: DuPont: Meeting to discuss | woensdag 10 maart 2021 10:07:35 image001.ong im 2.pni image003.png im. .Dn NEE Dear Yes we'll regard the meeting and documents as confidential.

Exemption of West Pharmaceutical's Medical Devices from the PFAS Restriction 1.